Journal rankings · indicator year 2004
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2004
Rheumatology journal rankings 2004
30 ranked journals · Subfield in Medicine
Rheumatology has 30 ranked journals in 2004. The median OJR rose 0.08 on 2003 to 0.88, below the world average of 1.00; Q1 starts at OJR 1.54. The top three are Arthritis & Rheumatism, Seminars in Arthritis and Rheumatism, and Current Opinion in Rheumatology.
Ranks and citation indicators: 2004. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2001–2003, the window the 2004 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery391
- Pulmonary and Respiratory Medicine152
- Public Health, Environmental and Occupational Health137
- Cardiology and Cardiovascular Medicine136
- Oncology109
- Epidemiology94
- Infectious Diseases86
- Psychiatry and Mental health82
- Radiology, Nuclear Medicine and Imaging71
- Neurology68
- Physiology67
- Endocrinology, Diabetes and Metabolism65
- Rheumatology30
Show all 42 subfields
- Orthopedics and Sports Medicine51
- Dermatology49
- Hematology49
- Pediatrics, Perinatology and Child Health49
- Ophthalmology43
- Obstetrics and Gynecology38
- Pharmacology30
- Nephrology28
- Reproductive Medicine25
- Emergency Medicine23
- Complementary and alternative medicine21
- Otorhinolaryngology18
- Pathology and Forensic Medicine16
- Rehabilitation16
- Geriatrics and Gerontology14
- Critical Care and Intensive Care Medicine13
- Immunology and Allergy13
- Genetics8
- Hepatology7
- Anesthesiology and Pain Medicine6
- Gastroenterology6
- Urology5
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
30 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2003. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2001–2003, the window the 2004 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2001–2003 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2004. | Compare |
|---|---|---|---|---|---|---|---|
1Arthritis & RheumatismWiley · United States | 2.93Q1 | 7.37 1.06 up from 2003 | 1,473 | 7% | — | ||
2Seminars in Arthritis and RheumatismElsevier BV · United States | 2.05Q1 | 4.38 1.05 up from 2003 | 132 | 2% | $4,370 | ||
3Current Opinion in RheumatologyLippincott Williams & Wilkins · United States | 1.98Q1 | 4.02 0.50 up from 2003 | 294 | 2% | — | ||
4Rheumatic Disease Clinics of North AmericaElsevier BV · United States | 1.82Q1 | 3.02 0.78 down from 2003 | 144 | 0% | $3,500 | ||
5Osteoarthritis and CartilageElsevier BV · United Kingdom | 1.65Q1 | 3.58 0.05 down from 2003 | 367 | 96% | $3,700 | ||
6Arthritis ResearchOABioMed Central · United Kingdom | 1.56Q1 | 3.48 0.07 up from 2003 | 108 | 100% | — | ||
7Arthritis Care & ResearchWiley · United States | 1.55Q1 | 3.12 0.17 down from 2003 | 245 | 13% | $4,640 | ||
8Annals of the Rheumatic DiseasesBMJ · United Kingdom | 1.54Q1 | 3.73 0.81 up from 2003 | 1,104 | 91% | $4,870 | ||
9British journal of rheumatologyOxford University Press · United Kingdom | 1.33Q2 | 2.75 0.28 up from 2003 | 798 | 21% | — | ||
10International Urogynecology JournalSpringer Science+Business Media · United Kingdom | 1.32Q2 | 1.63 1.03 down from 2003 | 273 | 5% | $3,790 | ||
11Lara D. VeekenOxford University Press · United Kingdom | 1.28Q2 | 3.29 0.43 up from 2003 | 243 | 29% | $4,597 | ||
12Best Practice & Research Clinical RheumatologyElsevier BV · Netherlands | 1.20Q2 | 2.33 0.54 up from 2003 | 162 | 3% | $4,180 | ||
13Autoimmunity ReviewsElsevier BV · Netherlands | 1.18Q2 | 2.76 1.59 up from 2003 | 134 | 1% | $4,730 | ||
14LupusSAGE Publishing · United Kingdom | 0.96Q2 | 2.17 0.41 up from 2003 | 453 | 4% | $4,150 | ||
15Current Rheumatology ReportsSpringer Science+Business Media · United States | 0.91Q2 | 2.11 0.24 up from 2003 | 207 | 0% | $4,490 | ||
16Connective Tissue ResearchTaylor & Francis · United Kingdom | 0.85Q3 | 1.85 0.83 up from 2003 | 213 | 7% | — | ||
17Scandinavian Journal of RheumatologyTaylor & Francis · United Kingdom | 0.76Q3 | 1.75no change | 211 | 3% | — | ||
18Clinical RheumatologySpringer Science+Business Media · Belgium | 0.56Q3 | 1.24 0.34 up from 2003 | 345 | 3% | $4,890 | ||
19Rheumatology InternationalSpringer Science+Business Media · Germany | 0.53Q3 | 1.02 0.15 up from 2003 | 195 | 3% | $4,990 | ||
20Joint Bone SpineElsevier BV · France | 0.53Q3 | 1.07 0.20 up from 2003 | 386 | 1% | $3,020 | ||
21Arthritis Research & TherapyOABioMed Central · United Kingdom | 0.38Q3 | 2.05 1.34 up from 2003 | 383 | 100% | $3,690 | ||
22Zeitschrift für RheumatologieSpringer Science+Business Media · Germany | 0.25Q3 | 0.46 0.01 down from 2003 | 164 | 1% | $3,390 | ||
23PteridinesOADe Gruyter Open · Germany | 0.22Q3 | 0.48 0.17 up from 2003 | 42 | 100% | $1,808 | ||
24Journal of Pelvic Medicine and SurgeryLippincott Williams & Wilkins · United States | 0.22Q4 | 0.32no 2003 value | 31 | 1% | — | — | |
25La Revue de Médecine InterneElsevier BV · France | 0.21Q4 | 0.52 0.26 up from 2003 | 770 | 1% | $2,300 | ||
26JCR Journal of Clinical RheumatologyLippincott Williams & Wilkins · United States | 0.11Q4 | 0.28 0.07 down from 2003 | 248 | 1% | — | ||
27Modern RheumatologyOxford University Press · United States | 0.05Q4 | 0.18 0.09 up from 2003 | 206 | 1% | $3,208 | ||
28APLAR Journal of RheumatologyWiley · Singapore | 0.04Q4 | 0.06 0.06 up from 2003 | 34 | 2% | — | ||
29Revista española de reumatología: Órgano Oficial de la Sociedad Española de ReumatologíaPublisher not listed | 0.02Q4 | 0.03 0.06 down from 2003 | 182 | 0% | — | ||
30Revista Brasileira de ReumatologiaOAElsevier BV · Brazil | 0.00Q4 | 0.00no 2003 value | 35 | 100% | $2,490 | — |
Subfields of Medicine, with Rheumatology highlighted.
- Surgery391
- Pulmonary and Respiratory Medicine152
- Public Health, Environmental and Occupational Health137
- Cardiology and Cardiovascular Medicine136
- Oncology109
- Epidemiology94
- Infectious Diseases86
- Psychiatry and Mental health82
- Radiology, Nuclear Medicine and Imaging71
- Neurology68
- Physiology67
- Endocrinology, Diabetes and Metabolism65
- Orthopedics and Sports Medicine51
- Dermatology49
- Hematology49
- Pediatrics, Perinatology and Child Health49
- Ophthalmology43
- Obstetrics and Gynecology38
- Pharmacology30
- Rheumatology30
- Nephrology28
- Reproductive Medicine25
- Emergency Medicine23
- Complementary and alternative medicine21
- Otorhinolaryngology18
- Pathology and Forensic Medicine16
- Rehabilitation16
- Geriatrics and Gerontology14
- Critical Care and Intensive Care Medicine13
- Immunology and Allergy13
- Genetics8
- Hepatology7
- Anesthesiology and Pain Medicine6
- Gastroenterology6
- Urology5
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2004. Corpus-wide, 69.4% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
8 additional Rheumatology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2001–2003, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2004. Publication window: 2001–2003. How these summaries are calculated
- Ranked journals
- 30
- Window papers (baseline)
- 25,269 +22.2% from indicator year 2001
- Median OJR
- 0.884 +13.1% from indicator year 2001
- Rising journals (2025)
- 6
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2001–2003 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 20 | 24 | 25 | 27 | 30 | 32 | 37 | 38 | 38 | 39 | 43 | 49 | 53 | 56 | 59 | 58 | 58 | 65 | 65 | 67 | 69 | 67 | 65 | 67 | 67 | 70 | |
| Window papers (baseline) | 17,821 | 20,685 | 22,377 | 24,459 | 25,269 | 27,867 | 30,643 | 33,672 | 36,348 | 39,439 | 42,988 | 46,086 | 48,179 | 49,400 | 51,214 | 53,341 | 54,578 | 55,366 | 56,123 | 57,306 | 59,410 | 62,541 | 65,720 | 67,501 | 67,701 | 69,555 | |
| Median OJR | 0.91 | 0.782 | 0.862 | 0.81 | 0.884 | 1.05 | 0.855 | 0.803 | 0.92 | 0.891 | 0.7969 | 0.888 | 0.877 | 0.95 | 0.879 | 0.847 | 0.9574 | 0.889 | 0.873 | 0.93 | 0.99 | 0.9569 | 0.869 | 0.851 | 0.785 | 0.7970 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.